Posts Tagged ‘amylin’

Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment
The Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals, Inc. announced today that they have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide, an analog of the human hormone amylin, with insulin to treat type 1 diabetes.

Read more on News-Medical-Net

Listen to Patrick Boyle, MD, lead physician of Diabetes Care Management at the University of New Mexico and a well-known endocrinologist thought leader, provide the key elements for successful pramlintide initiation and titration for your type 1 diabetes patients, as well as some clinical pearls on how to avoid the various barriers and pitfalls you may encounter. Provided by the Institute for Diabetes, Obesity, and Cardiovascular Disease (iDOC), a free resource for continuing medical education and other tools for medical professionals focused on the treatment of these three related conditions. Visit www.idoc.org for more information.